Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypersensitivity Reaction

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    September 2018
  1. PATEL K, Singam V, Vakharia PP, Chopra R, et al
    Measurement properties of three assessments of burden used in atopic dermatitis in adults.
    Br J Dermatol. 2018 Sep 23. doi: 10.1111/bjd.17243.
    PubMed     Text format     Abstract available


    August 2018
  2. CLASSEN A, Buhl T, Schubert S, Worm M, et al
    The frequency of specific contact allergies is reduced in psoriasis patients.
    Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17080.
    PubMed     Text format     Abstract available


  3. CLAUSEN ML, Edslev SM, Norreslet LB, Sorensen JA, et al
    Temporal Variation of Staphylococcus aureus clonal complexes in Atopic Dermatitis - a follow up study.
    Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17033.
    PubMed     Text format     Abstract available


  4. THYSSEN JP
    The trade-off: evolutionary benefits of epidermal filaggrin deficiency on cheek skin came at the price of the atopic dermatitis epidemic.
    Br J Dermatol. 2018;179:235-236.
    PubMed     Text format    


    July 2018
  5. HULSHOF L, Hack DP, Hasnoe QCJ, Dontje B, et al
    Stratum corneum analysis provide a minimal invasive tool to study immune response and skin barrier in atopic dermatitis children.
    Br J Dermatol. 2018 Jul 10. doi: 10.1111/bjd.16994.
    PubMed     Text format     Abstract available


  6. THYSSEN JP, Egeberg A
    Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16939.
    PubMed     Text format     Abstract available


  7. TSAKOK T, Woolf R, Smith CH, Weidinger S, et al
    Atopic dermatitis: the skin barrier and beyond.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16934.
    PubMed     Text format     Abstract available


  8. BRANDWEIN M, Fuks G, Israel A, Nejman D, et al
    Identification of a unique Staphylococcus aureus ribosomal signature in severe atopic dermatitis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16936.
    PubMed     Text format     Abstract available


    June 2018
  9. AHLSTROM MG, Thyssen JP, Menne T, Midander K, et al
    Short contact with nickel causes allergic contact dermatitis: an experimental study.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16935.
    PubMed     Text format     Abstract available


  10. MOCHIZUKI H, Lavery MJ, Nattkemper LA, Albornoz C, et al
    Impact of Acute Stress on Itch Sensation and Scratching Behavior in Atopic Dermatitis Patients and Healthy Controls.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16921.
    PubMed     Text format     Abstract available


  11. KALAKI E, Mizara A
    The role of parenting experiences, rather than age of onset or presence of the skin condition, in the development of maladaptive schemas in a community sample of patients with atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16920.
    PubMed     Text format     Abstract available


  12. HURAULT G, Schram ME, Roekevisch E, Spuls PI, et al
    Relationship and probabilistic stratification of EASI and oSCORAD severity scores for atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16916.
    PubMed     Text format     Abstract available


  13. DRUCKER AM, Flohr C
    Revisiting atopic dermatitis and cardiovascular disease.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16891.
    PubMed     Text format     Abstract available


  14. VON KOBYLETZKI LB, Svensson A
    Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
    Br J Dermatol. 2018;178:1236-1237.
    PubMed     Text format    


  15. SEDDON O, Hughes H
    Staphylococcus aureus and atopic dermatitis: a complex relationship.
    Br J Dermatol. 2018;178:1234.
    PubMed     Text format    


  16. DRUCKER AM, Flohr C
    Atopic dermatitis and cardiovascular disease: have we seen enough to refute a causal link?
    Br J Dermatol. 2018;178:1235-1236.
    PubMed     Text format    


    May 2018
  17. ZHU TH, Zhu TR, Tran KA, Sivamani RK, et al
    Epithelial Barrier Dysfunctions in Atopic Dermatitis: A Skin-Gut-Lung Model Linking Microbiome Alteration and Immune Dysregulation.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16734.
    PubMed     Text format     Abstract available


  18. HARKINS CP, McAleer MA, Bennett D, McHugh M, et al
    The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from Atopic Dermatitis patients.
    Br J Dermatol. 2018 May 5. doi: 10.1111/bjd.16722.
    PubMed     Text format     Abstract available


  19. SCHMITT J
    After the approval of dupilumab for moderate-to-severe atopic dermatitis: what is next on the research agenda?
    Br J Dermatol. 2018;178:992-993.
    PubMed     Text format    


    April 2018
  20. DARRIGADE AS, Legrand A, Andreu N, Jacquemin C, et al
    Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16711.
    PubMed     Text format     Abstract available


  21. MCALEER MA, Jakasa I, Raj N, O'Donnell CPF, et al
    Early life regional and temporal variation in filaggrin-derived natural moisturising factor, filaggrin processing enzyme activity, corneocyte phenotypes and plasmin activity: Implications for atopic dermatitis.
    Br J Dermatol. 2018 Apr 25. doi: 10.1111/bjd.16691.
    PubMed     Text format     Abstract available


  22. OOSTERHAVEN JAF
    Interpretability in atopic dermatitis: all about the anchor.
    Br J Dermatol. 2018;178:832-833.
    PubMed     Text format    


  23. KEZIC S
    Atopic dermatitis: risk estimates for hand eczema.
    Br J Dermatol. 2018;178:827.
    PubMed     Text format    


    March 2018
  24. ROLLS S, Rajan S, Shah A, Bourke JF, et al
    (Meth)acrylate allergy: frequently missed?
    Br J Dermatol. 2018 Mar 10. doi: 10.1111/bjd.16402.
    PubMed     Text format    


  25. ABUABARA K, Flohr C
    Is new better than tried and tested? Topical atopic dermatitis treatment in context.
    Br J Dermatol. 2018;178:583-584.
    PubMed     Text format    


  26. UTER W
    Extended patch-test screening for fragrance contact allergy: findings and challenges.
    Br J Dermatol. 2018;178:592-593.
    PubMed     Text format    


    February 2018
  27. NARLA S, Silverberg JI
    Association between childhood atopic dermatitis, cutaneous, extracutaneous and systemic infections.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16482.
    PubMed     Text format     Abstract available


  28. RENCZ F
    Impact of dupilumab on health-related quality of life in patients with atopic dermatitis.
    Br J Dermatol. 2018;178:319-320.
    PubMed     Text format    


  29. BISSONNETTE R
    JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.
    Br J Dermatol. 2018;178:321.
    PubMed     Text format    


    January 2018
  30. WANG R, Dunlap RR, Darwish MA, Simpson EL, et al
    Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality of life measure for adult atopic dermatitis.
    Br J Dermatol. 2018 Jan 30. doi: 10.1111/bjd.16398.
    PubMed     Text format     Abstract available


  31. KONO M, Akiyama M, Inoue Y, Nomura T, et al
    Filaggrin gene mutations may influence the persistence of food allergies in Japanese primary school children.
    Br J Dermatol. 2018 Jan 25. doi: 10.1111/bjd.16375.
    PubMed     Text format     Abstract available


  32. DIZON MP, Yu AM, Singh RK, Wan J, et al
    Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16340.
    PubMed     Text format     Abstract available


  33. DE BRUIN-WELLER M, Graham NMH, Pirozzi G, Shumel B, et al
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with Demodex and increased IL-17 levels? Reply from authors.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16348.
    PubMed     Text format     Abstract available


  34. THYSSEN JP
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with demodex and increased IL-17 levels?
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16330.
    PubMed     Text format     Abstract available


  35. THOMSON J, Wernham AGH, Williams HC
    Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    Br J Dermatol. 2018 Jan 6. doi: 10.1111/bjd.16317.
    PubMed     Text format     Abstract available


    December 2017
  36. DE WIT J, Totte JEE, van Buchem FJM, Pasmans SGMA, et al
    The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16251.
    PubMed     Text format     Abstract available


  37. GERBENS LAA, Hamann SAS, Brouwer MWD, Roekevisch E, et al
    Methotrexate and azathioprine in severe atopic dermatitis: a 5-year follow up study of a randomised controlled trial.
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16240.
    PubMed     Text format     Abstract available


  38. THYSSEN JP, Halling-Overgaard AS, Andersen YMF, Gislason G, et al
    The association between cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 6. doi: 10.1111/bjd.16215.
    PubMed     Text format     Abstract available


  39. AHMED A, Solman L, Williams HC
    Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal.
    Br J Dermatol. 2017 Dec 3. doi: 10.1111/bjd.16046.
    PubMed     Text format     Abstract available


  40. VAN DER BENT SAS, Maijer KI, Rustemeyer T
    Image Gallery: Hyperkeratotic hypersensitivity reaction to red pigment tattoo.
    Br J Dermatol. 2017;177:e350.
    PubMed     Text format    


    November 2017
  41. TOTTE JEE, Pardo LM, Fieten KB, de Wit J, et al
    The IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16153.
    PubMed     Text format     Abstract available


  42. PALLER AS
    Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16047.
    PubMed     Text format    


  43. DE BRUIN-WELLER M, Thaci D, Smith CH, Reich K, et al
    Dupilumab with concomitant topical corticosteroids in adult patients with atopic dermatitis who are not adequately controlled with or are intolerant to ciclosporin A, or when this treatment is medically inadvisable: a placebo-controlled, randomized ph
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16156.
    PubMed     Text format     Abstract available


  44. RUFF SMD, Engebretsen KA, Zachariae C, Johansen JD, et al
    The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16147.
    PubMed     Text format     Abstract available


  45. NAKAMURA-NISHIMURA Y, Miyagawa F, Miyashita K, Ommori R, et al
    Serum thymus and activation-regulated chemokine (TARC) is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS).
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16132.
    PubMed     Text format     Abstract available


  46. DANBY SG
    Staphylococcus aureus in atopic dermatitis: a diverse problem?
    Br J Dermatol. 2017;177:1164.
    PubMed     Text format    


  47. DRUCKER AM
    Making sense of measures of clinical signs for atopic dermatitis.
    Br J Dermatol. 2017;177:1158-1159.
    PubMed     Text format    


  48. SILVERBERG JI
    Are moisturizers effective in the treatment of atopic dermatitis?
    Br J Dermatol. 2017;177:1154.
    PubMed     Text format    


  49. MELLERIO JE
    Neonatal aggressive systemic mastocytosis.
    Br J Dermatol. 2017;177:1167-1168.
    PubMed     Text format    


    October 2017
  50. VAKHARIA PP, Chopra R, Sacotte R, Patel N, et al
    Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16078.
    PubMed     Text format     Abstract available


  51. EGEBERG A
    Cardiometabolic disease in atopic dermatitis: the heart of the matter.
    Br J Dermatol. 2017;177:898-899.
    PubMed     Text format    


  52. SEMINARA NM, Pomeranz MK
    Unravelling the links between malignancy, cytokines and neutrophilic eruptions.
    Br J Dermatol. 2017;177:905-906.
    PubMed     Text format    


  53. ASERO R
    Towards a better categorization of patients with chronic urticaria.
    Br J Dermatol. 2017;177:903-904.
    PubMed     Text format    


    September 2017
  54. NAKAGAWA H, Nemoto O, Igarashi A, Nagata T, et al
    Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study.
    Br J Dermatol. 2017 Sep 28. doi: 10.1111/bjd.16014.
    PubMed     Text format     Abstract available


  55. NOREN P, Hagstromer L, Alimohammadi M, Melin L, et al
    The positive effects of habit reversal treatment of scratching in children with atopic dermatitis: A randomised controlled study.
    Br J Dermatol. 2017 Sep 23. doi: 10.1111/bjd.16009.
    PubMed     Text format     Abstract available


  56. SIGURGEIRSSON B, Luger T
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15849.
    PubMed     Text format    


    June 2017
  57. AGNER T
    Biomarkers in contact dermatitis.
    Br J Dermatol. 2017;176:1434-1435.
    PubMed     Text format    


    April 2017
  58. SPULS PI, Gerbens LAA, Simpson E, Apfelbacher CJ, et al
    Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
    Br J Dermatol. 2017;176:979-984.
    PubMed     Text format     Abstract available


  59. NANKERVIS H, Thomas KS, Delamere FM, Barbarot S, et al
    What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.
    Br J Dermatol. 2017;176:910-927.
    PubMed     Text format     Abstract available


  60. KHANDPUR S, Porter RM, Boulton SJ, Anstey A, et al
    Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science.
    Br J Dermatol. 2017;176:902-909.
    PubMed     Text format     Abstract available


  61. BROWN SJ
    Evidence-based medicine for atopic eczema: identifying the knowns and unknowns.
    Br J Dermatol. 2017;176:842-844.
    PubMed     Text format    


    March 2017
  62. HUANG A, Fiadorchanka N, Brar K, Balderacchi JL, et al
    In-Utero Presentation of Aggressive Systemic Mastocytosis in a Neonate.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15506.
    PubMed     Text format     Abstract available


  63. TEO Y, Walsh S, Creamer D
    Cutaneous Adverse Drug Reactions Referrals to a Liaison Dermatology Service.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15461.
    PubMed     Text format     Abstract available


  64. ADLER NR, Aung AK, Ergen EN, Trubiano J, et al
    Recent advances in the understanding of severe cutaneous adverse reactions.
    Br J Dermatol. 2017 Mar 3. doi: 10.1111/bjd.15423.
    PubMed     Text format     Abstract available


    February 2017
  65. SU JC, Dailey R, Zallmann M, Leins E, et al
    Determining Effects of Superfine Sheep wool in INfantile Eczema (DESSINE): a randomized paediatric cross over study.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15376.
    PubMed     Text format     Abstract available


  66. TAN CW, Pang Y, Sim B, Thirumoorthy T, et al
    The association between drugs and bullous pemphigoid.
    Br J Dermatol. 2017;176:549-551.
    PubMed     Text format    


  67. STROM MA, Silverberg JI
    Association between atopic dermatitis and extracutaneous infections in US adults.
    Br J Dermatol. 2017;176:495-497.
    PubMed     Text format    


  68. THANDAR Y, Gray A, Botha J, Mosam A, et al
    Topical herbal medicines for atopic eczema: a systematic review of randomized controlled trials.
    Br J Dermatol. 2017;176:330-343.
    PubMed     Text format     Abstract available


  69. YE YM, Hur GY, Kim SH, Ban GY, et al
    Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome.
    Br J Dermatol. 2017;176:378-386.
    PubMed     Text format     Abstract available


  70. VACCARO M, Santarpia M, Calapai G, Mannucci C, et al
    Mucocutaneous toxicity induced by pegylated liposomal doxorubicin: a single-institution, retrospective case series.
    Br J Dermatol. 2017;176:507-509.
    PubMed     Text format    


  71. LEE HY, Walsh SA, Creamer D
    Long term complications of Stevens-Johnson syndrome / Toxic epidermal necrolysis: The spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multi-disciplinary follow up.
    Br J Dermatol. 2017 Feb 1. doi: 10.1111/bjd.15360.
    PubMed     Text format     Abstract available


    January 2017
  72. BISHNOI A, Parsad D, Vinay K, Kumaran MS, et al
    Phototherapy using narrowband ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid-dependent antihistamine-refractory chronic urticaria: a randomized, prospective observer-blinded comparative study.
    Br J Dermatol. 2017;176:62-70.
    PubMed     Text format     Abstract available


  73. FLYNN A, Molony P, Keeting C, Cullen J, et al
    Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.
    Br J Dermatol. 2017;176:e2.
    PubMed     Text format    


  74. GORCZYZA M, Schoepke N, Krause K, Hawro T, et al
    Patients with chronic cold urticaria may benefit from doxycycline therapy.
    Br J Dermatol. 2017;176:259-261.
    PubMed     Text format    


  75. VOLKER-TOUW CM, de Koning HD, Giltay JC, de Kovel CG, et al
    Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype.
    Br J Dermatol. 2017;176:244-248.
    PubMed     Text format    


  76. THOMSEN SF
    Effectiveness of phototherapy in chronic urticaria.
    Br J Dermatol. 2017;176:8.
    PubMed     Text format    


    December 2016
  77. HERMS F, Franck N, Kramkimel N, Fichel F, et al
    Neutrophilic eccrine hidradenitis in 2 patients treated with BRAF inhibitors: a new cutaneous adverse event.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15259.
    PubMed     Text format     Abstract available


  78. HELANDER A, Bradley M, Hasselblad A, Norlen L, et al
    Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.
    Br J Dermatol. 2016 Dec 14. doi: 10.1111/bjd.15174.
    PubMed     Text format     Abstract available


    November 2016
  79. BERENTS TL, Lodrup Carlsen KC, Mowinckel P, Skjerven HO, et al
    Transepidermal water loss in infancy associated with atopic eczema at 2 years: a population-based cohort study.
    Br J Dermatol. 2016 Nov 3. doi: 10.1111/bjd.15157.
    PubMed     Text format     Abstract available


  80. TOMIDA E, Kato Y, Ozawa H, Hasegawa H, et al
    Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    Br J Dermatol. 2016;175:1106-1108.
    PubMed     Text format    


    October 2016
  81. NOWROUZIAN FL, Lina G, Hodille E, Lindberg E, et al
    Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema.
    Br J Dermatol. 2016 Oct 19. doi: 10.1111/bjd.15138.
    PubMed     Text format     Abstract available


  82. LARESE FILON F, Plazzotta S, Rui F, Mauro M, et al
    Ten years incidence of contact dermatitis in a prospective cohort of health care workers in Trieste Hospitals (North East of Italy) 2004-2013.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15118.
    PubMed     Text format     Abstract available


    August 2016
  83. PAPO M, Valeyrie-Allanore L, Razazi K, Carteaux G, et al
    Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14934.
    PubMed     Text format     Abstract available


  84. WALSH S, Lew T, Lee HY
    Psychological sequelae of toxic epidermal necrolysis: further insights.
    Br J Dermatol. 2016;175:241.
    PubMed     Text format    


    July 2016
  85. CHONG HT, Yang GN, Sidhu S, Ibbetson J, et al
    Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2016 Jul 4. doi: 10.1111/bjd.14842.
    PubMed     Text format     Abstract available


  86. MOLIN S
    Deciphering the lipidomic profile of irritant contact dermatitis.
    Br J Dermatol. 2016;175:20-1.
    PubMed     Text format    


    May 2016
  87. PETRELLI F, Borgonovo K, Cabiddu M, Coinu A, et al
    Antibiotic prophylaxis for skin toxicity induced by anti-EGFR agents: a systematic review and meta-analysis.
    Br J Dermatol. 2016 May 23. doi: 10.1111/bjd.14756.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: